Results 161 to 170 of about 9,532 (200)

Serum Osteocalcin in Pediatric Osteogenesis Imperfecta: Impact of Disease Type and Bisphosphonate Therapy. [PDF]

Int J Mol Sci
Nowicki JK, Jakubowska-Pietkiewicz E.
europepmc   +1 more source

The Emerging Roles of Nano Drug Delivery Systems in Treatment of Osteoporosis-Current Knowledge, Challenges and Future Perspectives. [PDF]

Int J Nanomedicine
Yin P, Dong S, Yu J, Zhao Z, Hu Y.
europepmc   +1 more source

No Significant Improvement in Osteoporosis Management of Post-fragility Fracture Patients From 2010 to 2019: A National Database Study. [PDF]

J Am Acad Orthop Surg Glob Res Rev
Smith HD, Smith S, Turner N, Friess D, Working Z, DeKeyser G, Yoo J.   +6 more
europepmc   +1 more source

Safety in Spine Surgery: Risk Factors for Intraoperative Blood Loss and Management Strategies. [PDF]

Life (Basel)
Rybaczek M, Kowalski P, Mariak Z, Grabala M, Suszczyńska J, Łysoń T, Grabala P.   +6 more
europepmc   +1 more source

A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis. [PDF]

Osteoporos Int
Seefried L, Ferrari S, Páll D, Viapiana O, Rosa J, Supronik J, Licheva RN, Kiefer J, Jeszenői N, Horvát-Karajz K, Jókai E, Takács I.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Molecular imaging in oncology: Current impact and future directions

Ca-A Cancer Journal for Clinicians, 2022
Steven P Rowe, Martin G Pomper
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

[New bone density conservation agents for osteoporosis under research and development: Ibandronate].

Nihon rinsho. Japanese journal of clinical medicine, 2008
Ikuko, Tanaka, Junko, Hashimoto, Hisaji, Oshima   +2 more
openaire   +1 more source

[New bone density conservation agents for osteoporosis under research and development: ED-71].

, 2007
Hiroshi Hagino
openalex  

[New bone density conservation agents for osteoporosis under research and development: Zoledronate].

Nihon rinsho. Japanese journal of clinical medicine, 2008
Seiki, Wada, Takeshi, Fukawa, Sadahiro, Kamiya   +2 more
openaire   +1 more source